Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex E Clark

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|September 6, 2024
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in miceAaron F Carlin, James R Beadle, Jeremy Ardanuy, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Interferon-Inducible Guanylate-Binding Protein 5 Inhibits Replication of Multiple Viruses by Binding to the Oligosaccharyltransferase Complex and Inhibiting Glycoprotein MaturationShaobo Wang, Wanyu Li, Lingling Wang, et al.
ACS Infectious Diseases|October 21, 2021
Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome CoronavirusOscar A Ortega-Rivera, Sourabh Shukla, Matthew D Shin, et al.
Mbio|November 17, 2025
Interferon-inducible guanylate-binding protein 5 inhibits replication of multiple viruses by binding to the oligosaccharyltransferase complex and inhibiting glycoprotein maturationShaobo Wang, Wanyu Li, Jing Wen, et al.
Plos Pathogens|July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Plos Pathogens|November 25, 2025
Correction: Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Cancer Research|December 14, 2021
Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in GlioblastomaArko Sen, Briana C Prager, Cuiqing Zhong, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika VirusJean A Bernatchez, Zunhua Yang, Michael Coste, et al.
Viruses|April 24, 2019
Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem CellsJean A Bernatchez, Michael Coste, Sungjun Beck, et al.
Plos Pathogens|May 18, 2021
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activitySang Ho Park, Haley Siddiqi, Daniela V Castro, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|September 6, 2024
Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in miceAaron F Carlin, James R Beadle, Jeremy Ardanuy, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
Interferon-Inducible Guanylate-Binding Protein 5 Inhibits Replication of Multiple Viruses by Binding to the Oligosaccharyltransferase Complex and Inhibiting Glycoprotein MaturationShaobo Wang, Wanyu Li, Lingling Wang, et al.
ACS Infectious Diseases|October 21, 2021
Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome CoronavirusOscar A Ortega-Rivera, Sourabh Shukla, Matthew D Shin, et al.
Mbio|November 17, 2025
Interferon-inducible guanylate-binding protein 5 inhibits replication of multiple viruses by binding to the oligosaccharyltransferase complex and inhibiting glycoprotein maturationShaobo Wang, Wanyu Li, Jing Wen, et al.
Plos Pathogens|July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Plos Pathogens|November 25, 2025
Correction: Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Cancer Research|December 14, 2021
Leveraging Allele-Specific Expression for Therapeutic Response Gene Discovery in GlioblastomaArko Sen, Briana C Prager, Cuiqing Zhong, et al.
Antimicrobial Agents and Chemotherapy|August 1, 2018
Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika VirusJean A Bernatchez, Zunhua Yang, Michael Coste, et al.
Viruses|April 24, 2019
Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem CellsJean A Bernatchez, Michael Coste, Sungjun Beck, et al.
Plos Pathogens|May 18, 2021
Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activitySang Ho Park, Haley Siddiqi, Daniela V Castro, et al.
Pageof 6